Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
about
Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesisExpression of evolutionarily novel genes in tumorsKeeping abreast with long non-coding RNAs in mammary gland development and breast cancerAutochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and NanogDNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cellsSpecific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.Pseudogenes as weaknesses of ACTB (Actb) and GAPDH (Gapdh) used as reference genes in reverse transcription and polymerase chain reactionsExpression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cellsEmbryonic stem cell-specific signatures in cancer: insights into genomic regulatory networks and implications for medicineEpigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.Relationship of Oct-4 to malignant stage: a meta-analysis based on 502 positive/high Oct-4 cases and 522 negative/low case-free controls.The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer.Biliary tree stem cells, precursors to pancreatic committed progenitors: evidence for possible life-long pancreatic organogenesis.Aiming to immune elimination of ovarian cancer stem cellsDendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells.Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives.Octamer-binding transcription factors: genomics and functions.Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.Knockdown of OCT4 may sensitize NSCLC cells to cisplatin.Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell LinesPseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.Pseudogenes in gastric cancer pathogenesis: a review article.Functional OCT4-specific CD4(+) and CD8(+) T cells in healthy controls and ovarian cancer patients.Overexpression of OCT4 is associated with gefitinib resistance in non-small cell lung cancer.Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.Differential expression of Oct4 in HPV-positive and HPV-negative cervical cancer cells is not regulated by DNA methyltransferase 3A.Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cells.Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomesNew insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma
P2860
Q21134097-CF86B951-FBD5-4876-BB54-21B35E97F284Q26738894-C355EC4B-1B3D-4A03-923E-6411E43FC415Q26849813-3FD666E5-7E0A-4F24-B88B-5347CC83EC41Q28487410-9D2118AB-B491-47BD-87CB-797F221A9B38Q30537160-A3B4A2D1-AF19-4AF5-9203-707F26084597Q33994380-3DC01915-D140-48FB-A7FE-B4C08A80BAC5Q34395392-87EBED4B-A3F4-4C35-AA56-EE43042B8D0FQ35107589-02432652-E25F-47D5-B3FF-3814320924D5Q35840641-6DD72919-C759-4497-8934-03CCFB3738A1Q35877700-32D7DEF7-CADD-4F64-AF9E-A9ED60E3C20BQ35936614-4741A419-0CAC-4654-81FA-07CEEE9995C3Q36739064-99498ED0-333D-453F-92D4-59160CB20F54Q36857674-30032D43-2EE4-4601-B143-A9F8A830539DQ37228093-9CD199AD-FBE8-4EA4-9DCE-E0100C082CFCQ37266548-CEA42849-16AB-4D9D-A25A-1E7E8F0C0A54Q37490603-9C9C7A42-3D2C-4BEC-AE6F-BE3537BE3D9CQ38010413-CA5F2127-D595-40A0-BAFE-90C3B61B9959Q38112991-9F5832D6-3A52-4819-BAB7-D51F9787C668Q38527414-368E818D-CFE0-49A0-AC0E-1C6998A151D0Q38731917-26FD2054-63E0-49DD-A2C1-56BF4E986905Q38780061-0027F144-2EE4-480F-A754-3FA143639F39Q39161179-23AC9940-BD2B-4A91-B1EA-BD218E66C49AQ39275455-145E832E-0517-4E43-B623-6D03D7E40D21Q41220323-41F94196-8EC0-461F-84D6-872003BEC43BQ42158350-2225F12F-C6D0-4F09-AEA2-1F7A53F82549Q43092220-67D9F78A-0BA8-477D-882E-0C83F545FBDAQ53285743-1CBB49C7-E8BB-4AB0-A09F-D12B20F5775CQ55296648-4CA2601C-0CDE-461B-A6C7-6E2F8BA59DFAQ55424304-7BC9CC22-AC9B-4DB7-A6FD-8F6AC4BE1DAEQ55461517-6DD231D2-9E6F-4259-ACE6-8332487B37FCQ57032028-C67D6658-A210-4685-8055-58C1F1FB5DDCQ58572038-4F9DFFED-A8FE-40F1-B67B-E517F797FC85
P2860
Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Expression of OCT4 pseudogenes ...... m glioma and breast carcinoma.
@en
Expression of OCT4 pseudogenes ...... m glioma and breast carcinoma.
@nl
type
label
Expression of OCT4 pseudogenes ...... m glioma and breast carcinoma.
@en
Expression of OCT4 pseudogenes ...... m glioma and breast carcinoma.
@nl
prefLabel
Expression of OCT4 pseudogenes ...... m glioma and breast carcinoma.
@en
Expression of OCT4 pseudogenes ...... m glioma and breast carcinoma.
@nl
P2093
P2860
P356
P1476
Expression of OCT4 pseudogenes ...... m glioma and breast carcinoma.
@en
P2093
Eng-Ang Ling
Hongbo Hao
Huijuan Liu
Jianli Wang
Qiuhuan Yuan
Shangming Liu
Shidou Zhao
P2860
P304
P356
10.1002/PATH.2827
P577
2011-02-21T00:00:00Z